Drug & Gene Delivery

Deposition under magnification

UVA is widely recognized for its strengths in biopanning for novel peptide ligands in vivo, as well as using peptides and antibodies to target the delivery of microbubbles, liposomes and genes in the settings of cancer, cardiovascular and infectious disease.The combination of targeted drug and gene delivery with molecular imaging and systems biology provides a strong interdisciplinary foundation for the development and testing of novel targeted pharmaceuticals, as well as the revival and re-purposing of known small-molecule drugs with off-target effects that can now be corrected by targeted delivery.

BME Primary Faculty in this Area

Shannon Barker

Associate Professor, Academic General Faculty, Teaching Track, Biomedical Engineering, Undergraduate Program Director
Shannon Barker, Ph.D., focuses on ensuring that the BME undergraduate program's educational objectives and learning outcomes, as well as its curriculum, reflect an innovative and highly effective learning environment that meets the needs of all of its students, as well as employers, graduate &…

Bryan Berger

Associate Professor

Bryan received and his PhD in chemical engineering from the University of Delaware. He was a post-doctoral fellow in the department of biochemistry & biophysics at the University of Pennsylvania School of Medicine. Currently Bryan is associate professor of chemical engineering with a joint appointment in biomedical engineering.

Brent A. French

Professor, Biomedical Engineering

Brent A. French combines advanced methods of targeted drug and gene delivery with biomedical imaging in vivo to explore novel targets and treatment strategies in cardiovascular disease. Research interests of the Molecular Bioengineering Lab focus on developing new, more effective strategies for treating and preventing human disease.

John A. Hossack

Professor, Biomedical Engineering Professor, Electrical and Computer Engineering (By Courtesy)

John A. Hossack develops ultrasound imaging approaches for cardiovascular disease, including mouse heart imaging, catheter-based imaging and drug delivery, and molecular imaging for diagnosing stroke risk. He obtained B.Eng. and Ph.D. degrees in Electrical and Electronic Engineering, University of Strathclyde and his postdoc at Stanford University.

Kelsey Kubelick

Assistant Professor, Biomedical Engineering

Kelsey Kubelick leads an interdisciplinary, applications-driven lab developing advanced theranostic imaging techniques, particularly ultrasound and photoacoustic (PA) technologies.

Joint Faculty in Drug and Gene Delivery

Born and raised and educated (all the way past Ph.D.) in Moscow, then USSR, what is now Russia. In 1991 moved to USA and worked in academic research and industrial positions. Research interests are in the area of chemistry applications in biomedical research.

More about Drug and Gene Delivery at UVA

World’s First Focused Ultrasound Cancer Immunotherapy Center Will Be at UVA

The $8 million investment will generate clinical trials and other research that will directly benefit patients.